Market Pulse Archives

April 26, 2021, 7:14 a.m. EDT

Sanofi agrees to make Moderna COVID-19 vaccine in the U.S. starting in September

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Sanofi S.A. (SAN)
  • X
    Moderna Inc. (MRNA)
  • X
    BioNTech SE ADR (BNTX)

or Cancel Already have a watchlist? Log In

By Ciara Linnane

French drug maker Sanofi S.A. /zigman2/quotes/206928357/delayed FR:SAN -0.75% has agreed to make Moderna Inc.'s /zigman2/quotes/205619834/composite MRNA +4.50% COVID-19 vaccine at its site in Ridgefield, New Jersey, and will fill and finish up to 200 million doses starting in September. Chief Executive Paul Hudson said the company will also continue to work on its two COVID1-19 vaccine programs, while supporting the global effort. The move is Sanofi's third commitment to providing manufacturing support, and comes after it said it would make 125 million doses of the vaccine developed by BioNTech SE /zigman2/quotes/214419716/composite BNTX +2.32% and Pfizer Inc. /zigman2/quotes/202877789/composite PFE +2.15% for the European Union. In February, Sanofi said it would support Johnson & Johnson /zigman2/quotes/201724570/composite JNJ +0.02% by making about 12 million doses of that one-shot vaccine a month at a site in France. Sanofi is working with GlaxoSmithKline PLC /zigman2/quotes/200381158/delayed UK:GSK -1.23% to develop a COVID vaccine using the same recombinant protein-based manufacturing technology as one of its flu vaccines, combined with GSK's established pandemic adjuvant platform. Separately, it is working with Translate Bio to develop an mRNA vaccine.

/zigman2/quotes/206928357/delayed
FR : France: Euronext Paris
94.18
-0.71 -0.75%
Volume: 1.98M
Jan. 28, 2022 5:29p
P/E Ratio
20.44
Dividend Yield
3.40%
Market Cap
€119.12 billion
Rev. per Employee
€364,101
loading...
/zigman2/quotes/205619834/composite
US : U.S.: Nasdaq
$ 155.30
+6.68 +4.50%
Volume: 2.85M
Jan. 28, 2022 11:47a
P/E Ratio
9.49
Dividend Yield
N/A
Market Cap
$60.26 billion
Rev. per Employee
$9.10M
loading...
/zigman2/quotes/214419716/composite
US : U.S.: Nasdaq
$ 158.12
+3.58 +2.32%
Volume: 774,248
Jan. 28, 2022 11:47a
P/E Ratio
4.55
Dividend Yield
N/A
Market Cap
$37.48 billion
Rev. per Employee
$8.48M
loading...
/zigman2/quotes/202877789/composite
US : U.S.: NYSE
$ 54.52
+1.15 +2.15%
Volume: 9.58M
Jan. 28, 2022 11:47a
P/E Ratio
16.14
Dividend Yield
2.94%
Market Cap
$299.56 billion
Rev. per Employee
$883,274
loading...
/zigman2/quotes/201724570/composite
US : U.S.: NYSE
$ 170.63
+0.04 +0.02%
Volume: 3.77M
Jan. 28, 2022 11:47a
P/E Ratio
21.81
Dividend Yield
2.49%
Market Cap
$449.09 billion
Rev. per Employee
$697,212
loading...
/zigman2/quotes/200381158/delayed
UK : U.K.: London
1,660.40 p
-20.60 -1.23%
Volume: 7.07M
Jan. 28, 2022 4:29p
P/E Ratio
19.45
Dividend Yield
4.82%
Market Cap
£84.18 billion
Rev. per Employee
£354,283
loading...

This Story has 0 Comments
Be the first to comment
More News In
Industries

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.